This inventor holds 2 USPTO granted patents. Top assignee: Pharmacia Ab. Active years: 2005-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2006
Title: Innovations by Lars Sjöström in Treating Metabolic Syndrome
Introduction
Lars Sjöström is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of Metabolic Syndrome. With a total of 2 patents, his work focuses on innovative methods to address insulin resistance and related health issues.
Latest Patents
Lars Sjöström's latest patents include groundbreaking methods for treating patients with Metabolic Syndrome. One of his patents describes a method for treating patients exhibiting primary insulin resistance and lipoprotein aberrations or hypertension. This method involves administering human growth hormone or a functional analog in an effective amount to decrease these health issues. Another patent outlines a method aimed at decreasing insulin resistance in patients with abdominal or visceral obesity, again utilizing growth hormone or its functional derivatives.
Career Highlights
Throughout his career, Lars has been dedicated to advancing medical treatments for complex conditions. His innovative approaches have the potential to improve the quality of life for many patients suffering from Metabolic Syndrome. His work is recognized for its scientific rigor and practical applications in clinical settings.
Collaborations
Lars has collaborated with esteemed colleagues such as Gudmundur Johannsson and Per Björntorp. These partnerships have fostered a collaborative environment that enhances the development of effective treatment methods.
Conclusion
Lars Sjöström's contributions to the field of medicine through his patents on treating Metabolic Syndrome highlight his innovative spirit and commitment to improving patient care. His work continues to inspire advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile